Additionally, AMPK and its key downstream molecule mTOR play a significant role in maintaining cellular energy homeostasis and cell growth.[50, 51] Previous studies have shown that p‐p38α regulated gluconeogenesis as a negative regulator of AMPK signaling.[52] The dysregulation of the AMPK/mTOR pathway was also found in lymphoma,[53] which has been considered as a potential target for lymphoma treatment. The gene discussed is MTOR; the disease is lymphoma.